Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins

Cytokine and Growth Factor Reviews

Volumn 40, Issue , 2018, Pages 3-12

  Sauter, Daniel ^a   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Accessory proteins; HIV; Immune activation; Restriction factors; SIV

Indexed keywords

ANTIVIRUS AGENT; B LYMPHOCYTE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEF PROTEIN; PROTEASOME; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIF PROTEIN; VIRAL PROTEIN; VPR PROTEIN; VPU PROTEIN; VPX PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENDOSOME; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; INNATE IMMUNITY; LATENT VIRUS INFECTION; LENTIVIRUS; LYSOSOME; MICROBIAL DIVERSITY; NATURAL KILLER CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; UBIQUITINATION; VIRUS REPLICATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS;

HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; IMMUNE EVASION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NF-KAPPA B; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 85043393231     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2018.02.005     Document Type: Review

References (146)

1. Aranda, M., Maule, A., Virus-induced host gene shutoff in animals and plants. Virology 243 (1998), 261–267, 10.1006/viro.1998.9032.
2. Kluge, S.F., Sauter, D., Kirchhoff, F., SnapShot: antiviral restriction factors. Cell 163 (2015), 774–774.e1, 10.1016/j.cell.2015.10.019.
3. Clemens, M.J., PKR-a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29 (1997), 945–949.
4. Fros, J.J., Pijlman, G.P., Alphavirus infection host cell shut-off and inhibition of antiviral responses. Viruses, 8, 2016, 10.3390/v8060166.
5. Mohr, I., Virology Closing in on the causes of host shutoff. ELife, 5, 2016, e20755, 10.7554/eLife.20755.
6. Desforges, M., Charron, J., Bérard, S., Beausoleil, S., Stojdl, D.F., Despars, G., Laverdière, B., Bell, J.C., Talbot, P.J., Stanners, C.P., Poliquin, L., Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells. Virus Res. 76 (2001), 87–102, 10.1016/S0168-1702(01)00251-9.
7. Khaperskyy, D.A., McCormick, C., Timing is everything: coordinated control of host shutoff by influenza a virus NS1 and PA-X proteins. J. Virol. 89 (2015), 6528–6531, 10.1128/JVI.00386-15.
8. Toribio, R., Ventoso, I., Inhibition of host translation by virus infection in vivo. Proc. Natl. Acad. Sci. 107 (2010), 9837–9842, 10.1073/pnas.1004110107.
9. Walsh, D., Mohr, I., Viral subversion of the host protein synthesis machinery. Nat. Rev. Microbiol. 9 (2011), 860–875, 10.1038/nrmicro2655.
10. Kleinman, C.L., Doria, M., Orecchini, E., Giuliani, E., Galardi, S., De Jay, N., Michienzi, A., HIV-1 infection causes a down-regulation of genes involved in ribosome biogenesis. PLoS One, 9, 2014, 10.1371/journal.pone.0113908.
11. Van den Bergh, R., Florence, E., Vlieghe, E., Boonefaes, T., Grooten, J., Houthuys, E., Tran, H.T.T., Gali, Y., De Baetselier, P., Vanham, G., Raes, G., Transcriptome analysis of monocyte-HIV interactions. Retrovirology, 7, 2010, 53, 10.1186/1742-4690-7-53.
12. Chang, S.T., Sova, P., Peng, X., Weiss, J., Law, G.L., Palermo, R.E., Katze, M.G., Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. MBio, 2, 2011, 10.1128/mBio.00134-11.
13. Devadas, K., Biswas, S., Haleyurgirisetty, M., Wood, O., Ragupathy, V., Lee, S., Hewlett, I., Analysis of host gene expression profile in HIV-1 and HIV-2 infected T-cells. PLoS One, 11, 2016, e0147421, 10.1371/journal.pone.0147421.
14. Geiss, G.K., Bumgarner, R.E., An, M.C., Agy, M.B., van ’t Wout, A.B., Hammersmark, E., Carter, V.S., Upchurch, D., Mullins, J.I., Katze, M.G., Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266 (2000), 8–16, 10.1006/viro.1999.0044.
15. Mohammadi, P., Desfarges, S., Bartha, I., Joos, B., Zangger, N., Muñoz, M., Günthard, H.F., Beerenwinkel, N., Telenti, A., Ciuffi, A., 24 hours in the life of HIV-1 in a T cell line. PLoS Pathog., 9, 2013, e1003161, 10.1371/journal.ppat.1003161.
16. Li, M.D., Cao, J., Wang, S., Wang, J., Sarkar, S., Vigorito, M., Ma, J.Z., Chang, S.L., Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PLoS One, 8, 2013, e59582, 10.1371/journal.pone.0059582.
17. Cismasiu, V.B., Paskaleva, E., Suman Daya, S., Canki, M., Duus, K., Avram, D., BCL11 B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology 380 (2008), 173–181, 10.1016/j.virol.2008.07.035.
18. Avram, D., Califano, D., The multifaceted roles of Bcl11b in thymic and peripheral T cells − impact on immune diseases. J. Immunol. 193 (2014), 2059–2065, 10.4049/jimmunol.1400930.
19. Heusinger, E., Kirchhoff, F., Primate lentiviruses modulate NF-κB activity by multiple mechanisms to fine-tune viral and cellular gene expression. Front. Microbiol., 8, 2017, 198, 10.3389/fmicb.2017.00198.
20. Di Valentin, E., Bontems, S., Habran, L., Jolois, O., Markine-Goriaynoff, N., Vanderplasschen, A., Sadzot-Delvaux, C., Piette, J., Varicella-zoster virus IE63 protein represses the basal transcription machinery by disorganizing the pre-initiation complex. Biol. Chem. 386 (2005), 255–267, 10.1515/BC.2005.031.
21. Kalveram, B., Lihoradova, O., Ikegami, T., NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J. Virol. 85 (2011), 6234–6243, 10.1128/JVI.02255-10.
22. Kundu, P., Raychaudhuri, S., Tsai, W., Dasgupta, A., Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication. J. Virol. 79 (2005), 9702–9713, 10.1128/JVI.79.15.9702-9713.2005.
23. Vreede, F.T., Fodor, E., The role of the influenza virus RNA polymerase in host shut-off. Virulence 1 (2010), 436–439, 10.4161/viru.1.5.12967.
24. Fraser, K.A., Rice, S.A., Herpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase II. J. Virol. 81 (2007), 5091–5101, 10.1128/JVI. 00184-07.
25. Chan, J.K., Greene, W.C., Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol. Rev. 246 (2012), 286–310, 10.1111/j.1600-065X.2012.01094.x.
26. Sauter, D., Hotter, D., Van Driessche, B., Stürzel, C.M., Kluge, S.F., Wildum, S., Yu, H., Baumann, B., Wirth, T., Plantier, J.-C., Leoz, M., Hahn, B.H., Van Lint, C., Kirchhoff, F., Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins. Cell Rep. 10 (2015), 586–599, 10.1016/j.celrep.2014.12.047.
27. Hotter, D., Krabbe, T., Reith, E., Gawanbacht, A., Rahm, N., Ayouba, A., Van Driessche, B., Van Lint, C., Peeters, M., Kirchhoff, F., Sauter, D., Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation. PLoS Pathog., 13, 2017, e1006598, 10.1371/journal.ppat.1006598.
28. Postler, T.S., Desrosiers, R.C., The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1. Cell Host Microbe. 11 (2012), 181–193, 10.1016/j.chom.2011.12.005.
29. Akari, H., Bour, S., Kao, S., Adachi, A., Strebel, K., The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J. Exp. Med. 194 (2001), 1299–1311.
30. Bour, S., Perrin, C., Akari, H., Strebel, K., The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. J. Biol. Chem. 276 (2001), 15920–15928, 10.1074/jbc.M010533200.
31. Leulier, F., Marchal, C., Miletich, I., Limbourg-Bouchon, B., Benarous, R., Lemaitre, B., Directed expression of the HIV-1 accessory protein Vpu in drosophila fat-body cells inhibits toll-dependent immune responses. EMBO Rep. 4 (2003), 976–981, 10.1038/sj.embor.embor936.
32. Galão, R.P., Le Tortorec, A., Pickering, S., Kueck, T., Neil, S.J.D., Innate sensing of HIV-1 assembly by tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe 12 (2012), 633–644, 10.1016/j.chom.2012.10.007.
33. Schindler, M., Münch, J., Kutsch, O., Li, H., Santiago, M.L., Bibollet-Ruche, F., Müller-Trutwin, M.C., Novembre, F.J., Peeters, M., Courgnaud, V., Bailes, E., Roques, P., Sodora, D.L., Silvestri, G., Sharp, P.M., Hahn, B.H., Kirchhoff, F., Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125 (2006), 1055–1067, 10.1016/j.cell.2006.04.033.
34. Schmökel, J., Sauter, D., Schindler, M., Leendertz, F.H., Bailes, E., Dazza, M.-C., Saragosti, S., Bibollet-Ruche, F., Peeters, M., Hahn, B.H., Kirchhoff, F., The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses. J. Virol. 85 (2011), 742–752, 10.1128/JVI.02087-10.
35. Isakov, N., PKCθ is a key regulator of T-cell behavior and a drug target for t cell-mediated diseases. J. Clin. Cell. Immunol. 0 (2012), 1–7, 10.4172/2155-9899.S12-008.
36. Kirchhoff, F., Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution?. Nat. Rev. Microbiol. 7 (2009), 467–476, 10.1038/nrmicro2111.
37. Laguette, N., Brégnard, C., Hue, P., Basbous, J., Yatim, A., Larroque, M., Kirchhoff, F., Constantinou, A., Sobhian, B., Benkirane, M., Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156 (2014), 134–145, 10.1016/j.cell.2013.12.011.
38. Ayyavoo, V., Muthumani, K., Kudchodkar, S., Zhang, D., Ramanathan, P., Dayes, N.S., Kim, J.J., Sin, J.-I., Montaner, L.J., Weiner, D.B., HIV-1 viral protein R compromises cellular immune function in vivo. Int. Immunol. 14 (2002), 13–22.
39. Harman, A.N., Nasr, N., Feetham, A., Galoyan, A., Alshehri, A.A., Rambukwelle, D., Botting, R.A., Hiener, B.M., Diefenbach, E., Diefenbach, R.J., Kim, M., Mansell, A., Cunningham, A.L., HIV blocks interferon induction in human dendritic cells and macrophages by dysregulation of TBK1. J. Virol. 89 (2015), 6575–6584, 10.1128/JVI.00889-15.
40. Kogan, M., Deshmane, S., Sawaya, B.E., Gracely, E.J., Khalili, K., Rappaport, J., Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein. J. Cell. Physiol. 228 (2013), 781–790, 10.1002/jcp.24226.
41. Muthumani, K., Choo, A.Y., Zong, W.-X., Madesh, M., Hwang, D.S., Premkumar, A., Thieu, K.P., Emmanuel, J., Kumar, S., Thompson, C.B., Weiner, D.B., The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1. Nat. Cell Biol. 8 (2006), 170–179, 10.1038/ncb1352.
42. Muthumani, K., Hwang, D.S., Dayes, N.S., Kim, J.J., Weiner, D.B., The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. DNA Cell Biol. 21 (2002), 689–695, 10.1089/104454902760330237.
43. Venkatachari, N.J., Majumder, B., Ayyavoo, V., Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function. Virology 358 (2007), 347–356, 10.1016/j.virol.2006.08.030.
44. Felzien, L.K., Woffendin, C., Hottiger, M.O., Subbramanian, R.A., Cohen, E.A., Nabel, G.J., HIV transcriptional activation by the accessory protein VPR, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 5281–5286.
45. Roux, P., Alfieri, C., Hrimech, M., Cohen, E.A., Tanner, J.E., Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74 (2000), 4658–4665.
46. Liang, Z., Liu, R., Lin, Y., Liang, C., Tan, J., Qiao, W., HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest. Virol. Sin. 30 (2015), 441–448, 10.1007/s12250-015-3654-8.
47. Liu, R., Lin, Y., Jia, R., Geng, Y., Liang, C., Tan, J., Qiao, W., HIV-1 vpr stimulates NF-κB and AP-1 signaling by activating TAK1. Retrovirology, 11, 2014, 45, 10.1186/1742-4690-11-45.
48. Liu, R., Tan, J., Lin, Y., Jia, R., Yang, W., Liang, C., Geng, Y., Qiao, W., HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β. Virology 439 (2013), 47–56, 10.1016/j.virol.2013.01.020.
49. Gangwani, M.R., Kumar, A., Multiple protein kinases via activation of transcription factors NF-κB, AP-1 and C/EBP-δ regulate the IL-6/IL-8 production by HIV-1 vpr in astrocytes. PLoS One, 10, 2015, e0135633, 10.1371/journal.pone.0135633.
50. Varin, A., Decrion, A.-Z., Sabbah, E., Quivy, V., Sire, J., Van Lint, C., Roques, B.P., Aggarwal, B.B., Herbein, G., Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 280 (2005), 42557–42567, 10.1074/jbc.M502211200.
51. Doehle, B.P., Chang, K., Rustagi, A., McNevin, J., McElrath, M.J., Gale, M., Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J. Virol. 86 (2012), 8367–8374, 10.1128/JVI.00423-12.
52. Park, S.Y., Waheed, A.A., Zhang, Z.-R., Freed, E.O., Bonifacino, J.S., HIV-1 vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor. J. Biol. Chem. 289 (2014), 35102–35110, 10.1074/jbc.M114.597062.
53. Manganaro, L., de Castro, E., Maestre, A.M., Olivieri, K., García-Sastre, A., Fernandez-Sesma, A., Simon, V., HIV vpu interferes with NF-κB activity but not with interferon regulatory factor 3. J. Virol. 89 (2015), 9781–9790, 10.1128/JVI.01596-15.
54. Hotter, D., Kirchhoff, F., Sauter, D., HIV-1 vpu does not degrade interferon regulatory factor 3. J. Virol. 87 (2013), 7160–7165, 10.1128/JVI.00526-13.
55. Kuramitsu, M., Hashizume, C., Yamamoto, N., Azuma, A., Kamata, M., Yamamoto, N., Tanaka, Y., Aida, Y., A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. Microbes Infect. 7 (2005), 1150–1160, 10.1016/j.micinf.2005.03.022.
56. Hashizume, C., Kuramitsu, M., Zhang, X., Kurosawa, T., Kamata, M., Aida, Y., Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition. Microbes Infect. 9 (2007), 490–497, 10.1016/j.micinf.2007.01.013.
57. Terada, Y., Yasuda, Y., Human immunodeficiency virus type 1 vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145. Mol. Cell. Biol. 26 (2006), 8149–8158, 10.1128/MCB.01170-06.
58. Firth, A.E., Brierley, I., Non-canonical translation in RNA viruses. J. Gen. Virol. 93 (2012), 1385–1409, 10.1099/vir.0.042499-0.
59. Merrick, W.C., Retrospective, eIF4F: A, J. Biol. Chem. 290 (2015), 24091–24099, 10.1074/jbc.R115.675280.
60. Kuyumcu-Martinez, N.M., Van Eden, M.E., Younan, P., Lloyd, R.E., Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol. Cell. Biol. 24 (2004), 1779–1790.
61. Kuyumcu-Martinez, N.M., Joachims, M., Lloyd, R.E., Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease. J.Virol 76 (2002), 2062–2074.
62. Kuyumcu-Martinez, M., Belliot, G., Sosnovtsev, S.V., Chang, K.-O., Green, K.Y., Lloyd, R.E., Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein. J. Virol. 78 (2004), 8172–8182, 10.1128/JVI.78.15.8172-8182.2004.
63. Gradi, A., Svitkin, Y.V., Imataka, H., Sonenberg, N., Proteolysis of human eukaryotic translation initiation factor eIF4GII but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 11089–11094.
64. Sommergruber, W., Ahorn, H., Klump, H., Seipelt, J., Zoephel, A., Fessl, F., Krystek, E., Blaas, D., Kuechler, E., Liebig, H.D., 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. Virology 198 (1994), 741–745.
65. Kerekatte, V., Keiper, B.D., Badorff, C., Cai, A., Knowlton, K.U., Rhoads, R.E., Cleavage of poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff?. J.Virol 73 (1999), 709–717.
66. Alvarez, E., Menéndez-Arias, L., Carrasco, L., The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J.Virol 77 (2003), 12392–12400.
67. Castelló A., Franco, D., Moral-López, P., Berlanga, J.J., Alvarez, E., Wimmer, E., Carrasco, L., HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLoS One, 4, 2009, e7997, 10.1371/journal.pone.0007997.
68. Perales, C., Carrasco, L., Ventoso, I., Cleavage of eIF4G by HIV-1 protease: effects on translation. FEBS Lett. 533 (2003), 89–94.
69. Hanson, P.J., Zhang, H.M., Hemida, M.G., Ye, X., Qiu, Y., Yang, D., IRES-dependent translational control during virus-induced endoplasmic reticulum stress and apoptosis. Front. Microbiol., 3, 2012, 92, 10.3389/fmicb.2012.00092.
70. Collins, D.R., Collins, K.L., HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion. PLoS Pathog., 10, 2014, e1003851, 10.1371/journal.ppat.1003851.
71. Seissler, T., Marquet, R., Paillart, J.C., Hijacking of the ubiquitin/proteasome pathway by the HIV auxiliary proteins. Viruses, 9, 2017, E322, 10.3390/v9110322.
72. Shen, Q.T., Ren, X., Zhang, R., Lee, I.H., Hurley, J.H., HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons. Science, 350, 2015, aac5137, 10.1126/science.aac5137.
73. Ren, X., Park, S.Y., Bonifacino, J.S., Hurley, J.H., How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4. Elife, 3, 2014, e01754, 10.7554/eLife.01754.
74. Jia, X., Weber, E., Tokarev, A., Lewinski, M., Rizk, M., Suarez, M., Guatelli, J., Xiong, Y., Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1. Elife, 3, 2014, e02362, 10.7554/eLife.02362.
75. Jia, X., Singh, R., Homann, S., Yang, H., Guatelli, J., Xiong, Y., Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef. Nat. Struct. Mol. Biol. 19 (2012), 701–706.
76. Strebel, K., HIV accessory proteins versus host restriction factors. Curr. Opin. Virol. 3 (2013), 692–699.
77. Sugden, S.M., Bego, M.G., Pham, T.N., Cohen, É.A., Remodeling of the host cell plasma membrane by HIV-1 nef and vpu: a strategy to ensure viral fitness and persistence. Viruses, 8, 2016, 67.
78. Simon, V., Bloch, N., Landau, N.R., Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat. Immunol. 16 (2015), 546–553.
79. Pereira, E.A., daSilva, L.L., HIV-1 nef: taking control of protein trafficking. Traffic 17 (2016), 976–996.
80. Kirchhoff, F., Schindler, M., Specht, A., Arhel, N., Münch, J., Role of Nef in primate lentiviral immunopathogenesis. Cell. Mol. Life Sci. 65 (2008), 2621–2636.
81. Roeth, J.F., Williams, M., Kasper, M.R., Filzen, T.M., Collins, K.L., HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell Biol. 167 (2004), 903–913.
82. Le Gall, S., Erdtmann, L., Benichou, S., Berlloz-Torrent, C., Liu, L., Benarous, R., Heard, J.M., Schwartz, O., Nef interacts with mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8 (1998), 483–495.
83. Stoneham, C.A., Singh, R., Jia, X., Xiong, Y., Guatelli, J., Endocytic activity of HIV-1 Vpu: phosphoserine-dependent interactions with clathrin adaptors. Traffic 18 (2017), 545–561.
84. Lama, J., The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr. HIV Res. 1 (2003), 167–184.
85. Rosa, A., Chande, A., Ziglio, S., de Sanctis, V., Bertorelli, R., Goh, S.L., McCauley, S.M., Nowosielska, A., Antonarakis, S.E., Luban, J., Santoni, F.A., Pizzato, M., HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature 526 (2015), 212–217.
86. Usami, Y., Wu, Y., Gottlinger, H.G., SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526 (2015), 218–223.
87. Swigut, T., Shohdy, N., Skowronski, J., Mechanism for down-regulation of CD28 by Nef. EMBO J. 20 (2001), 1593–1604.
88. Hrecka, K., Swigut, T., Schindler, M., Kirchhoff, F., Skowronski, J., Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1. J. Virol. 79 (2005), 10650–10659.
89. Stove, V., Van de Walle, I., Naessens, E., Coene, E., Stove, C., Plum, J., Verhasselt, B., Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta. J. Virol. 79 (2005), 11422–11433.
90. Schindler, M., Münch, J., Kutsch, O., Li, H., Santiago, M.L., Bibollet-Ruche, F., Müller-Trutwin, M.C., Novembre, F.J., Peeters, M., Courgnaud, V., Bailes, E., Roques, P., Sodora, D.L., Silvestri, G., Sharp, P.M., Hahn, B.H., Kirchhoff, F., Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125 (2006), 1055–1067.
91. Swigut, T., Greenberg, M., Skowronski, J., Cooperative interactions of simian immunodeficiency virus Nef, AP-2, and CD3-zeta mediate the selective induction of T-cell receptor-CD3 endocytosis. J. Virol. 77 (2003), 8116–8126.
92. Manrique, S., Sauter, D., Horenkamp, F.A., Lülf, S., Yu, H., Hotter, D., Anand, K., Kirchhoff, F., Geyer, M., Endocytic sorting motif interactions involved in Nef-mediated downmodulation of CD4 and CD3. Nat. Commun., 8, 2017, 442.
93. Stumptner-Cuvelette, P., Morchoisne, S., Dugast, M., Le Gall, S., Raposo, G., Schwartz, O., Benaroch, P., HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 12144–12149.
94. Schindler, M., Würfl, S., Benaroch, P., Greenough, T.C., Daniels, R., Easterbrook, P., Brenner, M., Münch, J., Kirchhoff, F., Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77 (2003), 10548–10556.
95. Toussaint, H., Gobert, F.X., Schindler, M., Banning, C., Kozik, P., Jouve, M., Kirchhoff, F., Benaroch, P., Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain. J. Virol. 82 (2008), 8373–8382.
96. Mitchell, R.S., Chaudhuri, R., Lindwasser, O.W., Tanaka, K.A., Lau, D., Murillo, R., Bonifacino, J.S., Guatelli, J.C., Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 Nef. J. Virol. 82 (2008), 7758–7767.
97. Hussain, A., Wesley, C., Khalid, M., Chaudhry, A., Jameel, S., Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation. J. Virol. 82 (2008), 893–902.
98. Starlets, D., Gore, Y., Binsky, I., Haran, M., Harpaz, N., Shvidel, L., Becker-Herman, S., Berrebi, A., Shachar, I., Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 15 (2006), 4807–4816.
99. Ghiglione, Y., Rodríguez, A.M., De Candia, C., Carobene, M., Benaroch, P., Schindler, M., Salomón, H., Turk, G., HIV-mediated up-regulation of invariant chain (CD74) correlates with generalized immune activation in HIV+ subjects. Virus Res. 163 (2012), 380–384.
100. Chaudhuri, R., Lindwasser, O.W., Smith, W.J., Hurley, J.H., Bonifacino, J.S., Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. J. Virol. 81 (2007), 3877–3890.
101. Lubben, N.B., Sahlender, D.A., Motley, A.M., Lehner, P.J., Benaroch, P., Robinson, M.S., HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2. Mol. Biol. Cell 18 (2007), 3351–3365.
102. Craig, H.M., Reddy, T.R., Riggs, N.L., Dao, P.P., Guatelli, J.C., Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 271 (2000), 9–17.
103. Janvier, K., Craig, H., Hitchin, D., Madrid, R., Sol-Foulon, N., Renault, L., Cherfils, J., Cassel, D., Benichou, S., Guatelli, J., HIV-1 Nef stabilizes the association of adaptor protein complexes with membranes. J. Biol. Chem. 278 (2003), 8725–8732.
104. Coleman, S.H., Van Damme, N., Day, J.R., Noviello, C.M., Hitchin, D., Madrid, R., Benichou, S., Guatelli, J.C., Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes. J. Virol. 79 (2005), 2066–2078.
105. Luo, H., Interplay between the virus and the ubiquitin-proteasome system: molecular mechanism of viral pathogenesis. Curr. Opin. Virol. 17 (2016), 1–10.
106. Feng, Y., Baig, T.T., Love, R.P., Chelico, L., Suppression of APOBEC3-mediated restriction of HIV-1 by vif. Front. Microbiol., 5, 2014, 450.
107. Olson, M.E., Harris, R.S., Harki, D.A., APOBEC enzymes as targets for virus and cancer therapy. Cell Chem. Biol. 25 (2018), 36–49.
108. Desrosiers, R.C., Lifson, J.D., Gibbs, J.S., Czajak, S.C., Howe, A.Y., Arthur, L.O., Johnson, R.P., Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72 (1998), 1431–1437.
109. Tomonaga, K., Norimine, J., Shin, Y.S., Fukasawa, M., Miyazawa, T., Adachi, A., Toyosaki, T., Kawaguchi, Y., Kai, C., Mikami, T., Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66 (1992), 6181–6185.
110. Dettenhofer, M., Cen, S., Carlson, B.A., Kleiman, L., Yu, X.F., Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol. 74 (2000), 8938–8945.
111. Duggal, N.K., Emerman, M., Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 12 (2012), 687–695.
112. McLaughlin, R.N. Jr, Gable, J.T., Wittkopp, C.J., Emerman, M., Malik, H.S., Conservation and innovation of APOBEC3A restriction functions during primate evolution. Mol. Biol. Evol. 33 (2016), 1889–1901.
113. Schubert, U., Antón, L.C., Bacík, I., Cox, J.H., Bour, S., Bennink, J.R., Orlowski, M., Strebel, K., Yewdell, J.W., CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72 (1998), 2280–2288.
114. Margottin, F., Bour, S.P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., Benarous, R., A novel human WD protein h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1 (1998), 565–574.
115. Magadán, J.G., Pérez-Victoria, F.J., Sougrat, R., Ye, Y., Strebel, K., Bonifacino, J.S., Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog., 6, 2010, e1000869.
116. Schmidt, S., Fritz, J.V., Bitzegeio, J., Fackler, O.T., Keppler, O.T., HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio, 2, 2011, 10.1128/mBio.00036-11 (e00036-11).
117. Ramirez, P.W., DePaula-Silva, A.B., Szaniawski, M., Barker, E., Bosque, A., Planelles, V., HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Retrovirology, 12, 2015, 65.
118. Tokarev, A.A., Munguia, J., Guatelli, J.C., Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu. J. Virol. 85 (2011), 51–63.
119. Galão, R.P., Le Tortorec, A., Pickering, S., Kueck, T., Neil, S.J., Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe 12 (2012), 633–644.
120. Moll, M., Andersson, S.K., Smed-Sörensen, A., Sandberg, J.K., Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116 (2010), 1876–1884.
121. Shah, A.H., Sowrirajan, B., Davis, Z.B., Ward, J.P., Campbell, E.M., Planelles, V., Barker, E., Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8 (2010), 397–409.
122. Matusali, G., Potestà M., Santoni, A., Cerboni, C., Doria, M., The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J. Virol. 86 (2012), 4496–4504.
123. Apps, R., Del Prete, G.Q., Chatterjee, P., Lara, A., Brumme, Z.L., Brockman, M.A., Neil, S., Pickering, S., Schneider, D.K., Piechocka-Trocha, A., Walker, B.D., Thomas, R., Shaw, G.M., Hahn, B.H., Keele, B.F., Lifson, J.D., Carrington, M., HIV-1 vpu mediates HLA-C downregulation. Cell Host Microbe 19 (2016), 686–695.
124. Faust, T.B., Binning, J.M., Gross, J.D., Frankel, A.D., Making sense of multifunctional proteins: human immunodeficiency virus type 1 accessory and regulatory proteins and connections to transcription. Annu. Rev. Virol. 4 (2017), 241–260.
125. González, M.E., The HIV-1 vpr protein: a multifaceted target for therapeutic intervention. Int. J. Mol. Sci., 18, 2017, E126.
126. Hrecka, K., Hao, C., Shun, M.C., Kaur, S., Swanson, S.K., Florens, L., Washburn, M.P., Skowronski, J., HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E3921–3930.
127. Wu, Y., Zhou, X., Barnes, C.O., DeLucia, M., Cohen, A.E., Gronenborn, A.M., Ahn, J., Calero, G., The DDB1-DCAF1-Vpr-UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction. Nat. Struct. Mol. Biol. 23 (2016), 933–940.
128. Lahouassa, H., Blondot, M.L., Chauveau, L., Chougui, G., Morel, M., Leduc, M., Guillonneau, F., Ramirez, B.C., Schwartz, O., Margottin-Goguet, F., HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 5311–5316.
129. Zhou, X., DeLucia, M., Hao, C., Hrecka, K., Monnie, C., Skowronski, J., Ahn, J., HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase. J. Biol. Chem. 292 (2017), 21117–21127.
130. Laguette, N., Brégnard, C., Hue, P., Basbous, J., Yatim, A., Larroque, M., Kirchhoff, F., Constantinou, A., Sobhian, B., Benkirane, M., Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156 (2014), 134–145.
131. Fregoso, O.I., Emerman, M., Activation of the DNA damage response is a conserved function of HIV-1 and HIV-2 vpr that is independent of SLX4 recruitment. MBio 7 (2016), e01433–16.
132. Tristem, M., Marshall, C., Karpas, A., Petrik, J., Hill, F., Origin of vpx in lentiviruses. Nature 347 (1990), 341–342.
133. Lim, E.S., Fregoso, O.I., McCoy, C.O., Matsen, F.A., Malik, H.S., Emerman, M., The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11 (2012), 194–204.
134. Wei, W., Guo, H., Han, X., Liu, X., Zhou, X., Zhang, W., Yu, X.F., A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest. Cell. Microbiol. 14 (2012), 1745–1756.
135. Schwefel, D., Boucherit, V.C., Christodoulou, E., Walker, P.A., Stoye, J.P., Bishop, K.N., Taylor, I.A., Molecular determinants for recognition of divergent SAMHD1 proteins by the lentiviral accessory protein Vpx. Cell Host Microbe 17 (2015), 489–499.
136. Schaller, T., Bauby, H., Hué S., Malim, M.H., Goujon, C., New insights into an X-traordinary viral protein. Front. Microbiol., 5, 2014, 126.
137. Laguette, N., Rahm, N., Sobhian, B., Chable-Bessia, C., Münch, J., Snoeck, J., Sauter, D., Switzer, W.M., Heneine, W., Kirchhoff, F., Delsuc, F., Telenti, A., Benkirane, M., Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11 (2012), 205–217.
138. Fregoso, O.I., Ahn, J., Wang, C., Mehrens, J., Skowronski, J., Emerman, M., Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog., 9, 2013, e1003496.
139. Spragg, C.J., Emerman, M., Antagonism of SAMHD1 is actively maintained in natural infections of simian immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 21136–21141.
140. Calantone, N., Wu, F., Klase, Z., Deleage, C., Perkins, M., Matsuda, K., Thompson, E.A., Ortiz, A.M., Vinton, C.L., Ourmanov, I., Loré K., Douek, D.C., Estes, J.D., Hirsch, V.M., Brenchley, J.M., Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity 41 (2014), 493–502.
141. Foster, T.L., Wilson, H., Iyer, S.S., Coss, K., Doores, K., Smith, S., Kellam, P., Finzi, A., Borrow, P., Hahn, B.H., Neil, S.J.D., Resistance of transmitted founder HIV-1 to IFITM-mediated restriction. Cell Host Microbe 20 (2016), 429–442.
142. Sauter, D., Schindler, M., Specht, A., Landford, W.N., Münch, J., Kim, K.A., Votteler, J., Schubert, U., Bibollet-Ruche, F., Keele, B.F., Takehisa, J., Ogando, Y., Ochsenbauer, C., Kappes, J.C., Ayouba, A., Peeters, M., Learn, G.H., Shaw, G., Sharp, P.M., Bieniasz, P., Hahn, B.H., Hatziioannou, T., Kirchhoff, F., Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6 (2009), 409–421.
143. Sauter, D., Hué S., Petit, S.J., Plantier, J.C., Towers, G.J., Kirchhoff, F., Gupta, R.K., HIV-1 Group P is unable to antagonize human tetherin by Vpu Env or Nef. Retrovirology, 8, 2011, 103.
144. Kluge, S.F., Mack, K., Iyer, S.S., Pujol, F.M., Heigele, A., Learn, G.H., Usmani, S.M., Sauter, D., Joas, S., Hotter, D., Bibollet-Ruche, F., Plenderleith, L.J., Peeters, M., Geyer, M., Sharp, P.M., Fackler, O.T., Hahn, B.H., Kirchhoff, F., Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 16 (2014), 639–650.
145. Yang, S.J., Lopez, L.A., Exline, C.M., Haworth, K.G., Cannon, P.M., Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology, 8, 2011, 78.
146. Heigele, A., Kmiec, D., Regensburger, K., Langer, S., Peiffer, L., Stürzel, C.M., Sauter, D., Peeters, M., Pizzato, M., Learn, G.H., Hahn, B.H., Kirchhoff, F., The potency of nef-mediated serinc5 antagonism correlates with the prevalence of primate lentiviruses in the wild. Cell Host Microbe 20 (2016), 381–391, 10.1016/j.chom.2016.08.004.